Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial

Crit Care. 2019 Apr 29;23(1):148. doi: 10.1186/s13054-019-2447-0.

Mathilde Scarton¹, Anne Oppenheimer^{2

3}, Khalil Chaïbi¹, Didier Dreyfuss¹, Stéphane Gaudry^{4

5

6}

¹ AP-HP, Service de Réanimation Médico-Chirurgicale, Hôpital Louis Mourier, F-92700, Colombes, France.
² Service de Médecine de la Reproduction et Préservation de la fertilité, Hôpital Universitaire Antoine Béclère, Clamart, France.
³ EA 7285 Research Unit 'Risk and Safety in Clinical Medicine for Women and Perinatal Health', Versailles-Saint-Quentin University (UVSQ), Versailles, France.
⁴ AP-HP, Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, 93000, Bobigny, France. stephanegaudry@gmail.com.
⁵ French National Institute of Health and Medical Research (INSERM), UMR_S1155, Remodeling and Repair of Renal Tissue, Hôpital Tenon, F-75020, Paris, France. stephanegaudry@gmail.com.
⁶ Present Address: Intensive Care Unit, Hôpital Avicenne, 125 Rue de Stalingrad, 93000, Bobigny, France. stephanegaudry@gmail.com.

No abstract available

Publication types